Earlier this year, BIO launched our Value Campaign. One of the main goals of this effort is to shine a spotlight on the insurance industry’s efforts to restrict patients’ access to the medications they need.
For years, the insurance industry and its allies have made patients pay more for less coverage. That’s just plain wrong.
In the post-Affordable Care Act (ACA) age, insurers—banned from excluding patients with pre-existing conditions—have taken to more creative means to discourage sick people from enrolling in their plans – such as outrageously high out-of-pocket costs or 50% coinsurance for the medications they need.
